This provider averages 62 services per working day
Based on 155.2K total services over 10 years (250 working days/year). Learn about impossible service volumes →
This provider's $26.4M in total Medicare payments ranks in the 99th percentile of Ophthalmology providers nationally.
Averaging 62 services per working day raises questions about billing patterns.
Medicare payments to this provider grew 187% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 59% in 2020
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $403.99 | $193.64 | 2.09x | $210.35 | $1.3M | 6.9K | 14 |
| 2015 | $380.83 | $183.65 | 2.07x | $197.18 | $1.5M | 8.2K | 16 |
| 2016 | $446.62 | $207.75 | 2.15x | $238.87 | $1.5M | 7.2K | 17 |
| 2017 | $466.42 | $223.45 | 2.09x | $242.97 | $1.7M | 7.7K | 13 |
| 2018 | $401.01 | $212.81 | 1.88x | $188.20 | $2.0M | 9.2K | 15 |
| 2019 | $462.04 | $241.68 | 1.91x | $220.36 | $2.3M | 9.4K | 17 |
| 2020 | $500.80 | $267.54 | 1.87x | $233.26 | $3.6M | 13.5K | 16 |
| 2021 | $537.35 | $285.38 | 1.88x | $251.97 | $4.7M | 16.5K | 17 |
| 2022 | $383.83 | $189.67 | 2.02x | $194.16 | $4.0M | 20.9K | 14 |
| 2023 | $139.41 | $68.38 | 2.04x | $71.03 | $3.8M | 55.7K | 13 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 20.4K | $15.0M | $736.04 | 1.70x |
| J2778 | Injection, ranibizumab, 0.1 mg | 16.6K | $4.5M | $268.10 | 1.86x |
| 67028 | Injection of drug into eye | 18.8K | $1.6M | $83.91 | 4.24x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 53.6K | $1.6M | $29.27 | 1.95x |
| J0179 | Injection, brolucizumab-dbll, 1 mg | 3.5K | $882.3K | $249.25 | 1.67x |
| 92134 | Imaging of retina | 15.8K | $462.9K | $29.30 | 2.38x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 4.8K | $410.2K | $85.34 | 1.97x |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 2.4K | $380.3K | $157.93 | 1.72x |
| 92014 | Established patient complete exam of visual system | 4.0K | $318.3K | $79.58 | 2.35x |
| J3490 | Unclassified drugs | 142 | $249.5K | $1.8K | 3.14x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 4.6K | $243.4K | $53.02 | 2.10x |
| J9035 | Injection, bevacizumab, 10 mg | 3.1K | $173.6K | $55.49 | 2.64x |
| J7999 | Compounded drug, not otherwise classified | 2.1K | $137.1K | $66.31 | 4.45x |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | 1.9K | $113.0K | $58.42 | 2.14x |
| 67113 | Repair of detached retina and drainage of eye fluid between lens and retina | 63 | $73.9K | $1.2K | 3.54x |
| J3590 | Unclassified biologics | 38 | $73.4K | $1.9K | 1.83x |
| 67228 | Laser destruction of leaking retinal blood vessels, 1 or more sessions | 145 | $55.0K | $379.02 | 4.06x |
| 67041 | Removal of membrane from the retina | 53 | $49.0K | $923.74 | 3.45x |
| 67042 | Removal of membrane from the retina, pars plana approach | 38 | $33.5K | $880.87 | 3.94x |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | 260 | $24.1K | $92.67 | 2.43x |
This provider submits charges 1.98 times higher than what Medicare actually pays.
A markup ratio of 1.98x means for every $100 Medicare pays, this provider initially charges $198. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data